The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients

Autor: Sahar Abourida, Sahar M. Haydar, Bahia Chahine, Etwal Bou Raad, Souheil Hallit, Lama Faddoul

Publikováno v: Pharmacy Practice (Granada), Volume: 16, Issue: 4, Article number: 1220, Published: 21 OCT 2019
Pharmacy Practice, Vol 14, Iss 4, p 1220 (2018)
Pharmacy Practice (Granada) v.16 n.4 2018
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice

Objective: The objective of this study is to compute the potential benefit of Pramipexole ER on total levodopa equivalent dose (LED) and Unified Parkinson Disease Rating Score (UPDRS-III) compared to mono- or combined therapy of pramipexole IR and/or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee8bd06398c634659668597c9193a0db
https://doi.org/10.18549/pharmpract.2018.04.1220